KMC Speciality (KMCSHIL) | Financial Analysis & Statements
KMC Speciality Hospitals India Limited Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
665.5M
Gross Profit
561.9M
84.43%
Operating Income
113.7M
17.08%
Net Income
75.4M
11.32%
EPS (Diluted)
₹0.46
Balance Sheet Metrics
Total Assets
2.9B
Total Liabilities
1.2B
Shareholders Equity
1.6B
Debt to Equity
0.74
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
KMC Speciality Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.3B | 1.8B | 1.5B | 1.4B | 1.0B |
| Cost of Goods Sold | 336.8M | 244.2M | 229.7M | 205.6M | 163.2M |
| Gross Profit | 2.0B | 1.5B | 1.3B | 1.1B | 855.6M |
| Gross Margin % | 85.3% | 86.1% | 85.2% | 84.8% | 84.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 633.9M | 452.2M | 413.8M | 337.1M | 287.0M |
| Other Operating Expenses | 231.3M | 201.3M | 172.6M | 162.6M | 114.0M |
| Total Operating Expenses | 865.2M | 653.4M | 586.4M | 499.8M | 401.0M |
| Operating Income | 386.7M | 392.1M | 344.3M | 311.3M | 179.2M |
| Operating Margin % | 16.9% | 22.2% | 22.2% | 23.0% | 17.6% |
| Non-Operating Items | |||||
| Interest Income | 8.5M | 20.3M | 17.7M | 12.5M | 8.9M |
| Interest Expense | 94.2M | 11.6M | 8.1M | 7.0M | 9.5M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 316.0M | 405.6M | 359.9M | 321.0M | 180.4M |
| Income Tax | 101.8M | 101.8M | 93.0M | 83.7M | 52.6M |
| Effective Tax Rate % | 32.2% | 25.1% | 25.8% | 26.1% | 29.2% |
| Net Income | 214.3M | 303.8M | 266.9M | 237.3M | 127.8M |
| Net Margin % | 9.3% | 17.2% | 17.2% | 17.5% | 12.5% |
| Key Metrics | |||||
| EBITDA | 600.9M | 515.8M | 448.8M | 394.9M | 257.6M |
| EPS (Basic) | ₹1.31 | ₹1.86 | ₹1.64 | ₹1.45 | ₹0.78 |
| EPS (Diluted) | ₹1.31 | ₹1.86 | ₹1.64 | ₹1.45 | ₹0.78 |
| Basic Shares Outstanding | 163085000 | 163085000 | 163085000 | 163085000 | 163085000 |
| Diluted Shares Outstanding | 163085000 | 163085000 | 163085000 | 163085000 | 163085000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
KMC Speciality Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 91.9M | 48.5M | 18.4M | 16.7M | 21.3M |
| Short-term Investments | 79.7M | 178.3M | 369.5M | 314.9M | 155.7M |
| Accounts Receivable | 59.8M | 43.8M | 43.7M | 35.4M | 25.5M |
| Inventory | 35.0M | 20.5M | 22.7M | 18.7M | 17.5M |
| Other Current Assets | 15.2M | 12.5M | 18.3M | 11.5M | 11.3M |
| Total Current Assets | 332.4M | 335.2M | 518.6M | 424.8M | 261.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 976.6M | 738.5M | 423.0M | 345.8M | 313.0M |
| Goodwill | 441.0K | 648.0K | 3.9M | 8.0M | 5.0M |
| Intangible Assets | 441.0K | 648.0K | 3.9M | 8.0M | 5.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.6M | 600 | 6.0K | 6.0K | 971.0K |
| Total Non-Current Assets | 2.5B | 2.3B | 1.3B | 862.9M | 788.6M |
| Total Assets | 2.9B | 2.6B | 1.8B | 1.3B | 1.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 140.8M | 75.6M | 64.1M | 54.1M | 52.1M |
| Short-term Debt | 116.0M | 103.4M | 55.1M | 76.3M | 14.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 18.1M | 14.5M | 12.2M | 9.5M | 6.3M |
| Total Current Liabilities | 379.4M | 464.5M | 225.4M | 195.1M | 125.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | 778.5M | 714.8M | 444.3M | 211.5M | 275.6M |
| Deferred Tax Liabilities | 32.8M | 6.4M | 0 | 597.0K | 5.8M |
| Other Non-Current Liabilities | 1.0M | 811.0K | 802.0K | 1.1M | - |
| Total Non-Current Liabilities | 837.3M | 736.8M | 456.1M | 224.5M | 291.0M |
| Total Liabilities | 1.2B | 1.2B | 681.5M | 419.6M | 416.6M |
| Equity | |||||
| Common Stock | 163.1M | 163.1M | 163.1M | 163.1M | 163.1M |
| Retained Earnings | 1.5B | 1.3B | 978.7M | 711.8M | 474.5M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.6B | 1.4B | 1.1B | 868.0M | 633.3M |
| Key Metrics | |||||
| Total Debt | 894.5M | 818.2M | 499.4M | 287.8M | 290.4M |
| Working Capital | -47.0M | -129.3M | 293.1M | 229.7M | 135.6M |
Balance Sheet Composition
KMC Speciality Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 316.0M | 405.6M | 359.9M | 237.3M | 127.8M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -39.1M | -15.7M | -27.2M | -4.3M | 24.7M |
| Operating Cash Flow | 362.5M | 381.2M | 323.1M | 227.5M | 153.1M |
| Investing Activities | |||||
| Capital Expenditures | -638.7M | -752.4M | -441.0M | -134.8M | -408.2M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | -55.5M | -160.5M | -67.0M |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -638.7M | -752.4M | -496.5M | -294.6M | -475.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 186.8M | 355.7M | 191.4M | 13.4M | 229.6M |
| Debt Repayment | -91.6M | -76.7M | -15.2M | -14.1M | -37.7M |
| Financing Cash Flow | 95.3M | 279.0M | 176.2M | -618.0K | 191.9M |
| Free Cash Flow | -63.0M | -368.5M | -117.9M | 156.4M | -152.5M |
| Net Change in Cash | -180.9M | -92.2M | 2.9M | -67.7M | -130.1M |
Cash Flow Trend
KMC Speciality Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
40.06
Price to Book
8.09
Price to Sales
5.14
PEG Ratio
0.48
Profitability Ratios
Profit Margin
12.88%
Operating Margin
23.66%
Return on Equity
13.04%
Return on Assets
7.49%
Financial Health
Current Ratio
1.36
Debt to Equity
47.30
Beta
-0.13
Per Share Data
EPS (TTM)
₹2.24
Book Value per Share
₹11.09
Revenue per Share
₹17.41
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| KMCSHIL | 14.6B | 40.06 | 8.09 | 13.04% | 12.88% | 47.30 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Indraprastha Medical | 37.3B | 20.08 | 5.57 | 26.98% | 12.60% | 4.76 |
| Dr. Agarwal's Eye | 24.3B | 34.01 | 7.52 | 26.07% | 15.50% | 106.45 |
| Shalby | 16.7B | 207.28 | 1.75 | 0.63% | 0.72% | 53.32 |
Financial data is updated regularly. All figures are in the company's reporting currency.





